Seeing Is Believing
Currently out of the existing stock ratings of Alec Stranahan, 11 are a BUY (47.83%), 5 are a HOLD (21.74%), 7 are a SELL (30.43%).
Analyst Alec Stranahan works at BAML with a stock forecast success ratio of 57.44% fulfilled within 137.63 days on average.
Alec Stranahan’s has documented 46 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RVMD, Revolution Medicines at 05-Jan-2024.
Analyst best performing recommendations are on YMAB (Y MABS THERAPEUTICS).
The best stock recommendation documented was for TGTX (TG THERAPEUTICS) at 5/20/2022. The price target of $5 was fulfilled within 4 days with a profit of $0.39 (7.24%) receiving and performance score of 18.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$2.06 (106.19%)
6
3 months 14 days ago
0/5 (0%)
$2.83 (241.88%)
Hold
16
1 years 4 months 24 days ago
0/3 (0%)
$11.08 (225.20%)
Buy
6
$4.06 (209.28%)
13
1 years 4 months 25 days ago
3/14 (21.43%)
$3.49 (139.04%)
56
Buy
15
$13.06 (673.20%)
19
1 years 7 months 5 days ago
1/4 (25%)
$10.56 (237.84%)
185
Buy
14
$12.06 (621.65%)
14
1 years 10 months 22 days ago
0/3 (0%)
$10.2 (268.42%)
Which stock is Alec Stranahan is most bullish on?
Which stock is Alec Stranahan is most reserved on?
What Year was the first public recommendation made by Alec Stranahan?